Navigation Links
FDA News & Notes - Week of July 18, 2011
Date:7/18/2011

SILVER SPRING, Md., July 18, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of July 18, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Events and Speeches for the Commissioner and FDA leadership:
Monday, 7/25 – FDA Commissioner Margaret A. Hamburg discusses consumer and pharmaceutical issues as part of Public Citizen's 40th Anniversary Speaker Series Symposium. 12:30 p.m., 1600 20th Street, N.W., Washington, D.C. Send required RSVP to bholzer@citizen.org.
Press Office Contact: Raymond Formanek Jr., 301-796-4677, raymond.formanek@fda.hhs.gov

Meetings, Workshops and Congressional Testimony:
Wednesday, 7/20 – The Circulatory System Devices Panel of the Medical Devices Advisory Committee discusses and votes on information related to the premarket approval application for the Edwards SAPIEN Transcatheter Heart Valve sponsored by Edwards Lifesciences. 8 a.m., Hilton Washington D.C. North/Gaithersburg, 620 Perry Parkway, Gaithersburg, Md.
Press Office Contact: Amanda Sena, 301-796-0393, amanda.sena@fda.hhs.gov

Wednesday, 7/20 – Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee  discusses the drug development program of an investigational gastroenterology drug. Meeting is open to the public from 8 a.m. to 9 a.m. From 9 a.m. to 1 p.m., the meeting will be closed for discussion and review of trade secret and confidential commercial information. Hilton Washington, D.C./Silver Spring, 8727 Colesville Rd., Silver Spring, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov

Thursday, 7/21 – The Circulatory System Devices Panel of the Medical Devices Advisory Committee discusses and votes on the humanitarian device exemption for the Berlin Heart EXCOR Pediatric Ventricular Assist Device sponsored by Berlin Heart Inc. 8 a.m., Hilton Washington D.C. North/Gaithersburg, 620 Perry Parkway, Gaithersburg, Md.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Thursday, 7/21 – Gastrointestinal Drugs Advisory Committee Meeting to discuss results from a clinical trial of supplement biologics license application 103772/5301, Remicade (infliximab), Centocor Ortho Biotech Inc., in the treatment of pediatric patients with moderately to severely active ulcerative colitis. 8 a.m., Hilton Washington, D.C./Silver Spring, 8727 Colesville Rd., Silver Spring, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov

Thursday, 7/21 – The Tobacco Products Scientific Advisory Committee meets to discuss changes proposed to the TPSAC Menthol Report submitted to the agency on March 18, 2011, and additional oral and written comments from the public. During an afternoon session, the committee discusses the nature and impact of the use of dissolvable tobacco products on the public health. 8 a.m., Center for Tobacco Products, 9200 Corporate Boulevard, Rockville, Md. The meeting will be webcast. See the CTP website for information.
Press Office Contact: Jeff Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov

Friday, 7/22 – The Tobacco Products Scientific Advisory Committee continues its discussion of the nature and impact of the use of dissolvable tobacco products on the public health. 8 a.m., Center for Tobacco Products, 9200 Corporate Boulevard, Rockville, Md. The meeting will be webcast. See the CTP website for information.
Press Office Contact: Jeff Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov

On the Web:
FDA Commissioner Hamburg announces a new agency initiative to encourage development of domestic medical products during a July 15, 2011, appearance at the City Club of Cleveland. Podcast available here.

FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov
List of FDA press officers and beats

More Resources:
FDA News and Events
FDA Photos (Flickr)
Consumer Health Information


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Robbins & Myers Announces Regular Quarterly Cash Dividend
6. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
7. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
8. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
9. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
10. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
11. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb 24, 2017 Research and ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... drug pricing data and benchmarks in the global Urinary Incontinence market. ... What are the key drugs marketed for Urinary Incontinence and ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO ... year. Dyer started as the Chairman of the Management Committee when IFN was ... corporation including the recruitment of investor/owners and development of the business plan. He ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, ... their Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, ... generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... jointly issued a letter to withdraw previous guidance issued by the ... identity. The guidance issued in May 2016 by the Obama Administration came in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to the La Gorce Country Club in Miami Beach to host its Swirl: ...
Breaking Medicine News(10 mins):